Lapatinib 68180-0801-36

Package NDC

68180-0801-36

Manufacturer: Lupin Pharmaceuticals, Inc.
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: September 29, 2020
Listing Expires: December 31, 2026
Application: ANDA203007

Need to source Lapatinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lapatinib Ditosylate	250 mg/1

Drug Class

Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]

Selected Package

68180-0801-36Selected

150 TABLET in 1 BOTTLE (68180-801-36)